KERNSPINTOMOGRAHIE ZUM METASTASEN-SCREENING? EIN PROSPEKTIVER VERGLEICH MIT DER SKELETTSZINTIGRAPHIE

P. Theissen; K. Smolarz; A. Scharl; A. Groth; K. Scheidhauer; E. Voth; H. Schicha

doi:10.1055/s-0038-1629807

KERNSPINTOMOGRAHIE ZUM METASTASEN-SCREENING? EIN PROSPEKTIVER VERGLEICH MIT DER SKELETTSZINTIGRAPHIE

Translated title of the contribution: Magnetic resonance imaging in screening for bone metastases? A prospective comparison with bone scintigraphy

P. Theissen, K. Smolarz, A. Scharl, A. Groth, K. Scheidhauer, E. Voth, H. Schicha

University of Cologne

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Abstract

To define the value of magnetic resonance imaging (MRI) in screening for bone metastases (BM) compared to bone scintigraphy (BSc) 102 patients with tumours with frequent BM were examined also by MRI of spine, pelvis, femora, and proximal tibiae. All patients had normal BSc and 96 (94%) normal MRI. Only 6% of the patients had focal abnormalities within the bone marrow. This indicates that there is a 94% probability of absence of BM if BSc is normal. Therefore, BSc should currently remain the method of choice for screening for BM. Despite MRI is sensitive and specific, with the common technique up to now it should not be used instead of BSc in screening because of costs, duration, and lack of whole body examination. MRI is a valuable adjunct in equivocal findings in BSc with negative results on radiographs.

Translated title of the contribution	Magnetic resonance imaging in screening for bone metastases? A prospective comparison with bone scintigraphy
Original language	German
Pages (from-to)	132-137
Number of pages	6
Journal	NuklearMedizin
Volume	33
Issue number	4
DOIs	https://doi.org/10.1055/s-0038-1629807
State	Published - 1994
Externally published	Yes

Access to Document

10.1055/s-0038-1629807

Cite this

@article{44f6522f36cf46d893e2514f84d80131,

title = "KERNSPINTOMOGRAHIE ZUM METASTASEN-SCREENING? EIN PROSPEKTIVER VERGLEICH MIT DER SKELETTSZINTIGRAPHIE",

abstract = "To define the value of magnetic resonance imaging (MRI) in screening for bone metastases (BM) compared to bone scintigraphy (BSc) 102 patients with tumours with frequent BM were examined also by MRI of spine, pelvis, femora, and proximal tibiae. All patients had normal BSc and 96 (94%) normal MRI. Only 6% of the patients had focal abnormalities within the bone marrow. This indicates that there is a 94% probability of absence of BM if BSc is normal. Therefore, BSc should currently remain the method of choice for screening for BM. Despite MRI is sensitive and specific, with the common technique up to now it should not be used instead of BSc in screening because of costs, duration, and lack of whole body examination. MRI is a valuable adjunct in equivocal findings in BSc with negative results on radiographs.",

keywords = "bone marrow, bone metastases, bone scintigraphy, magnetic resonance imaging, screening",

author = "P. Theissen and K. Smolarz and A. Scharl and A. Groth and K. Scheidhauer and E. Voth and H. Schicha",

year = "1994",

doi = "10.1055/s-0038-1629807",

language = "Deutsch",

volume = "33",

pages = "132--137",

journal = "NuklearMedizin",

issn = "0029-5566",

publisher = "Georg Thieme Verlag",

number = "4",

}

TY - JOUR

T1 - KERNSPINTOMOGRAHIE ZUM METASTASEN-SCREENING? EIN PROSPEKTIVER VERGLEICH MIT DER SKELETTSZINTIGRAPHIE

AU - Theissen, P.

AU - Smolarz, K.

AU - Scharl, A.

AU - Groth, A.

AU - Scheidhauer, K.

AU - Voth, E.

AU - Schicha, H.

PY - 1994

Y1 - 1994

N2 - To define the value of magnetic resonance imaging (MRI) in screening for bone metastases (BM) compared to bone scintigraphy (BSc) 102 patients with tumours with frequent BM were examined also by MRI of spine, pelvis, femora, and proximal tibiae. All patients had normal BSc and 96 (94%) normal MRI. Only 6% of the patients had focal abnormalities within the bone marrow. This indicates that there is a 94% probability of absence of BM if BSc is normal. Therefore, BSc should currently remain the method of choice for screening for BM. Despite MRI is sensitive and specific, with the common technique up to now it should not be used instead of BSc in screening because of costs, duration, and lack of whole body examination. MRI is a valuable adjunct in equivocal findings in BSc with negative results on radiographs.

AB - To define the value of magnetic resonance imaging (MRI) in screening for bone metastases (BM) compared to bone scintigraphy (BSc) 102 patients with tumours with frequent BM were examined also by MRI of spine, pelvis, femora, and proximal tibiae. All patients had normal BSc and 96 (94%) normal MRI. Only 6% of the patients had focal abnormalities within the bone marrow. This indicates that there is a 94% probability of absence of BM if BSc is normal. Therefore, BSc should currently remain the method of choice for screening for BM. Despite MRI is sensitive and specific, with the common technique up to now it should not be used instead of BSc in screening because of costs, duration, and lack of whole body examination. MRI is a valuable adjunct in equivocal findings in BSc with negative results on radiographs.

KW - bone marrow

KW - bone metastases

KW - bone scintigraphy

KW - magnetic resonance imaging

KW - screening

UR - http://www.scopus.com/inward/record.url?scp=0028169204&partnerID=8YFLogxK

U2 - 10.1055/s-0038-1629807

DO - 10.1055/s-0038-1629807

M3 - Artikel

C2 - 7971287

AN - SCOPUS:0028169204

SN - 0029-5566

VL - 33

SP - 132

EP - 137

JO - NuklearMedizin

JF - NuklearMedizin

IS - 4

ER -

KERNSPINTOMOGRAHIE ZUM METASTASEN-SCREENING? EIN PROSPEKTIVER VERGLEICH MIT DER SKELETTSZINTIGRAPHIE

Abstract

Access to Document

Other files and links

Fingerprint

Cite this